HSV-2疫苗评价方法研究进展
摘要
单纯疱疹病毒2型（HSV-2）是疱疹病毒科的典型代表，属于α疱疹病毒亚科，主要引起腰部以下的皮肤疱疹和生殖器疱疹。近期研究发现，
出处
《山东医药》
CAS
2013年第8期94-96,共3页
Shandong Medical Journal
基金
温州医学院本科科研立项课题(WYZ201201018)
参考文献25
-
1Pisani S, Imperi M, Seganti L, et al. Effect of HSV-2 infection on the expression of HPV 16 genes in CaSki cells [J]. Int J Immunopathol Pharmacol, 2004,17 ( 1 ) : 65-70.
-
2Barnabas RV, Wasserheit JN, Huang Y, et al. Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study) [ J]. J Acquit Immune Defic Syndr, 2011,57(3) :238-244.
-
3Suzanne MB, Ding Z, Riet E, et al. Advances in transcutaneous vaccine delivery: Do all ways lead to Rome [ J ]. J Control Release, 2010,148 (3) :266-282.
-
4William PH, Ringo P, Edward G, et al. A Live-Attenuated HSV- 2 ICP02 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein d subunit vaccine [J]. PLos One, 2011,6(3) :17748.
-
5khrameyeva NV, Zhang PW, Sugiyama N, et al. Development of L Glycoprotein D-Expressing Dominant-Negative and Replication-Defective Herpes Simplex Virus 2 (HSV-2) recombinant viral vaceine against HSV-2 Infection in Mice [J]. J Virol, 2011,85 10) :5036-5047.
-
6Reszka N J, Dudek T,Knipe DM,et al. Construction and properties of a herpes simplex virus 2 d15-29 vaccine candidate strain encoding an HSV-I virion host shutoff protein [J]. Vaccine, 2010,28 (15) :2754-2762.
-
7Meseda CA, Stout RR, Weir JP. Evaluation of a Needle-Free Delivery Platform for Prime-Boost Immunization with DNA and Modified Vaccinia Virus Ankara Vectors Expressing Herpes Simplex Vires 2 Glycoprotein D [ J ]. Viral Immunol, 2006,19 (2) : 250-259.
-
8Tengvall S, Josefsson A, Holmgren J, et al. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice [J]. J Reprod Immunol, 2005,68 ( 1-2 ) :53-69.
-
9Muller WJ, Dong LC, Vilaha A, et al. Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection [J]. J Gen Virol, 2009,90 ( Pt 5 ) : 1153-1163.
-
10Mo A, Mussellia C, Chena H, et al. A heat shock protein based polyvalent vaccine targeting HSV-2: CD4^+ and CD8^+ cellular immunity and protective efficacy [ J ]. Vaccine, 2011, 29 ( 47 ) : 8530-8541.
-
1魏强,王健伟,张扬清,鲍琳琳,涂新明,蒋虹,高红,丛喆,朱华,邓巍,佟巍,张兵林,黄澜,刘亚莉,秦川.恒河猴感染SARS-CoV的病毒学、血清学检测[J].中国实验动物学报,2005,13(3):144-146. 被引量：1
-
2赵红玲,章文,黄涛.甲型H1N1流感病毒基因特征及耐药性研究[J].中国病原生物学杂志,2014,9(9):811-815. 被引量：19
-
3王晶晶,张雪梅,赵红玲,董承红,普晶,廖芸,王丽春,纳锐雄,刘龙丁,张莹,杨丽仙,王庆林,沈冬,王玺,李琦涵.人肠道病毒71型感染免疫抑制恒河猴的分析[J].中国病理生理杂志,2011,27(7):1249-1256. 被引量：5
-
4张扬清,鲍琳琳,孔琪,邓巍,涂新明,朱华,高虹,张兵林,佟巍,秦川.SARS病原体的检测及其在动物模型鉴定及疫苗评价中的应用[J].中国比较医学杂志,2004,14(2):65-70. 被引量：5
-
5刘江宁,张连峰.人肠道病毒71型动物模型研究进展[J].中国实验动物学报,2010,18(3):275-278. 被引量：6
-
6鲍琳琳,涂新明,蒋虹,佟巍,丛喆,魏强,朱华,张扬清,高虹,邓巍,黄澜,刘亚莉,王健伟,秦川.SARS冠状病毒分离培养和鉴定的实验研究[J].病毒学报,2005,21(1):31-34. 被引量：1
-
7高恩明,谢贵林.疫苗评价中有关风险效益分析的思考[J].微生物学免疫学进展,2011,39(1):53-56.
-
8宋淑霞,闫彩珍,郑龙,尤红煜,王俊霞,刘福英.HLA-A＊0201／Kb及MAGE-3基因共转染B16细胞的制备及其在MAGE-3肿瘤疫苗评价中的作用[J].细胞与分子免疫学杂志,2008,24(7):679-682. 被引量：1
-
9魏强,王健伟,张扬清,鲍琳琳,涂新明,蒋虹,高红,丛喆,朱华,邓巍,佟巍,张兵林,黄澜,刘亚莉,秦川.SARS冠状病毒感染恒河猴的病毒、血清学检测研究[J].中国实验动物学报,2005,13(S1):37-38.
-
10俞芬娟.11例创伤弧菌致多形性皮肤疱疹的临床分析[J].中国医师杂志,2012,14(1):69-70. 被引量：1
